The use of forms of hyaluronic acid having a molecular weight less than about 750,000 daltons selected from the group consisting of hyaluronic acid and pharmaceutically acceptable salts thereof is provided for the same purposes known for using recombinant GM-CFS of G-CSF.

 
Web www.patentalert.com

< Combination therapy for treating protein deficiencies

> Benzylated PDE4 inhibitors

~ 00476